The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection
Open accessAbstract
Hepatitis B virus (HBV) is a prototype for liver-specific pathogens in which the failure of the immune system to mount an effective response leads to chronic infection. Our understanding of the immune response to HBV is incomplete, largely due to the narrow host restriction of this pathogen and the limitations of existing experimental models. We have developed a murine model for studying human HBV replication, immunogenicity, and control. After transfection of hepatocytes in vivo with a replication-competent, over-length, linear HBV genome, viral antigens and replicative intermediates were synthesized and virus was secreted into the blood. Viral antigens disappeared from the blood as early as 7 days after transfection, coincident with the appearance of antiviral antibodies. HBV transcripts and replicative intermediates disappeared from the liver by day 15, after the appearance of antiviral CD8 + T cells. In contrast, the virus persisted for at least 81 days after transfection of NOD/Scid mice, which lack functional T cells, B cells, and natural killer (NK) cells. Thus, the outcome of hydrodynamic transfection of HBV depends on the host immune response, as it is during a natural infection. The methods we describe will allow the examination of viral dynamics in a tightly controlled in vivo system, the application of mutagenesis methods to the study of the HBV life cycle in vivo, and the dissection of the immune response to HBV using genetically modified mice whose immunoregulatory and immune effector functions have been deleted or overexpressed. In addition, this methodology represents a prototype for the study of other known and to-be-discovered liver-specific pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727
Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,223
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Self-citationTHE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Self-citationNoncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Self-citationHigh-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Self-citationVital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection
Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R. C., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L. R., Scalzo, A. A., & Yokoyama, W. M. (2001) · Science · doi:10.1126/science.1060042 · Cited by 627
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
Kakimi, K., Guidotti, L. G., Koezuka, Y., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.921 · Cited by 584
Self-citationVirus of Pekin ducks with structural and biological relatedness to human hepatitis B virus
Mason, W. S., Seal, G., & Summers, J. W. (1980) · Journal of Virology · doi:10.1128/jvi.36.3.829-836.1980 · Cited by 514
Yant, S. R., Meuse, L., Chiu, W., Ivics, Z., Izsvak, Z., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/75568 · Cited by 509
NK cells and NKT cells in innate defense against viral infections
Biron, C. A., & Brossay, L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00241-7 · Cited by 426
Salazar-Mather, T. P., Orange, J. S., & Biron, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.1 · Cited by 375
Cytotoxic T cells and viral hepatitis.
Chisari, F. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119308 · Cited by 367
Self-citationChisari, F. V., Filippi, P., Buras, J., McLachlan, A., Popper, H., Pinkert, C. A., Palmiter, R. D., & Brinster, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6909 · Cited by 355
Self-citationPatterns of cytokine gene expression by CD4+ T cells from young and old mice
Hobbs, M. V., Weigle, W. O., Noonan, D. J., Torbett, B. E., McEvilly, R. J., Koch, R. J., Cardenas, G. J., & Ernst, D. N. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3602 · Cited by 350
Hirsch, R. C., Lavine, J. E., Chang, L.-J., Varmus, H. E., & Ganem, D. (1990) · Nature · doi:10.1038/344552a0 · Cited by 309
Chang, J., Sigal, L. J., Lerro, A., & Taylor, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3469-3473.2001 · Cited by 82
Human Class I Supertypes and CTL Repertoires Extend to Chimpanzees
Bertoni, R., Sette, A., Sidney, J., Guidotti, L. G., Shapiro, M., Purcell, R. H., & Chisari, F. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4447 · Cited by 76
Self-citationKuhröber, A. (1997) · International Immunology · doi:10.1093/intimm/9.8.1203 · Cited by 74
Host–Virus Interactions during Malaria Infection in Hepatitis B Virus Transgenic Mice
Pasquetto, V., Guidotti, L. G., Kakimi, K., Tsuji, M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.529 · Cited by 69
Self-citationMajor Differences between WHV and HBV in the Regulation of Transcription
Di, Q., Summers, J. W., Burch, J. B. E., & Mason, W. S. (1997) · Virology · doi:10.1006/viro.1996.8422 · Cited by 35
Cited by
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Li, J., Liu, K., Liu, Y., Xu, Y., Zhang, F., Yang, H., Liu, J., Pan, T., Chen, J., Wu, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2647 · Cited by 509
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
Wieland, S. F., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9369-9380.2005 · Cited by 457
Self-citation
Metadata
- Authors
- Yang, P. L., Althage, A., Chung, J., & Chisari, F. V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-08
- Volume
- 99
- Issue
- 21
- Pages
- 13825-13830
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986655312
- Cited by
- 380
- References
- 23
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.